News & Updates

Show Multimedia Only

Dapagliflozin prevents worsening heart failure, CV death

06 Oct 2022

Dapagliflozin is a safe treatment to reduce the risk of worsening heart failure (HF) or cardiovascular death both in patients with and without history of recent HF hospitalization, a study has shown.

Dapagliflozin prevents worsening heart failure, CV death

06 Oct 2022

PASCAL System augments treatment armamentarium for severe mitral regurgitation

06 Oct 2022 by

In the CLASP* IID trial, the PASCAL Transcatheter Valve Repair System demonstrated noninferiority to the MitraClip System for the treatment of severe symptomatic degenerative mitral regurgitation (DMR).

PASCAL System augments treatment armamentarium for severe mitral regurgitation

06 Oct 2022

Recalibrated FRS reduces overestimation, improves statin use

05 Oct 2022

Depending on the model being used, recalibration of risk scores using contemporary population-level data may improve risk stratification for statin therapy, suggests a study.

Recalibrated FRS reduces overestimation, improves statin use

05 Oct 2022

Trans fatty acid intake tied to hypertensive disorders of pregnancy

05 Oct 2022

Prepregnancy intakes of total fat, unsaturated fat, and monounsaturated fatty acid (MUFA) do not appear to contribute to hypertensive disorders of pregnancy (HDP), but trans fatty acid (TFA) shows a positive association with HDP, reports a study.

Trans fatty acid intake tied to hypertensive disorders of pregnancy

05 Oct 2022

Bashir catheter shows treatment potential for pulmonary embolism

05 Oct 2022 by

Pharmacomechanical catheter-directed thrombolysis (PM-CDT) using the Bashir endovascular catheter demonstrated potential for the treatment of intermediate-risk acute pulmonary embolism (PE), findings from the RESCUE* trial have shown.

Bashir catheter shows treatment potential for pulmonary embolism

05 Oct 2022

Tirzepatide confers renal protection in patients with T2D

05 Oct 2022 by

Once-weekly injection of tirzepatide, a dual GIP and GLP-1 receptor antagonist, slowed eGFR* decline and reduced UACR** in patients with type 2 diabetes (T2D) who are at high risk of cardiovascular (CV) disease compared with once-daily insulin glargine (iGlar), according to a prespecified post hoc analysis of the SURPASS-4*** trial presented at EASD 2022.

Tirzepatide confers renal protection in patients with T2D

05 Oct 2022

Aspirin prevents CVD in older adults with elevated lipoprotein(a) genotypes

04 Oct 2022

Use of aspirin offers health benefits to older individuals with elevated lipoprotein(a) genotypes by preventing cardiovascular events, suggests a study.

Aspirin prevents CVD in older adults with elevated lipoprotein(a) genotypes

04 Oct 2022

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

04 Oct 2022 by

The selective, oral sodium–glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin reduces the risk of cardiovascular (CV) death or worsening heart failure (HF) in patients with HF and mildly reduced or preserved ejection fraction (HFmrEF or HFpEF) in the phase III DELIVER* trial, touted as the largest and most inclusive thus far in this patient group.

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

04 Oct 2022

Hearts donated after circulatory vs brain death tied to post-transplant dysfunction

03 Oct 2022

Utilization of hearts donated after circulatory death (DCD) appears to result in transient post-transplant right heart dysfunction and short-term clinical outcomes otherwise comparable to transplantation using hearts donated after brain death (DBD), reveals a recent study.

Hearts donated after circulatory vs brain death tied to post-transplant dysfunction

03 Oct 2022

Reproductive factors implicated in atrial fibrillation risk in women

03 Oct 2022

Reproductive factors such as irregular menstrual cycles, nulliparity, and multiparity contribute to an increased risk of new-onset atrial fibrillation in women, as reported in a study.

Reproductive factors implicated in atrial fibrillation risk in women

03 Oct 2022

News & Updates

Showing Cardiology articles

Showing

Specialty:

Dapagliflozin prevents worsening heart failure, CV death

Dapagliflozin prevents worsening heart failure, CV death

PASCAL System augments treatment armamentarium for severe mitral regurgitation

PASCAL System augments treatment armamentarium for severe mitral regurgitation

Recalibrated FRS reduces overestimation, improves statin use

Recalibrated FRS reduces overestimation, improves statin use

Trans fatty acid intake tied to hypertensive disorders of pregnancy

Trans fatty acid intake tied to hypertensive disorders of pregnancy

Bashir catheter shows treatment potential for pulmonary embolism

Bashir catheter shows treatment potential for pulmonary embolism

Tirzepatide confers renal protection in patients with T2D

Tirzepatide confers renal protection in patients with T2D

Aspirin prevents CVD in older adults with elevated lipoprotein(a) genotypes

Aspirin prevents CVD in older adults with elevated lipoprotein(a) genotypes

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

Hearts donated after circulatory vs brain death tied to post-transplant dysfunction

Hearts donated after circulatory vs brain death tied to post-transplant dysfunction

Reproductive factors implicated in atrial fibrillation risk in women

Reproductive factors implicated in atrial fibrillation risk in women